M&AHealthcareSIGNED
Lilly Acquires Biotech with Drug Trials in Spain
Acquirer
Eli Lilly
Target
Biotech company
Eli Lilly has acquired a biotechnology company whose lead drug candidate is undergoing clinical trials in Spain. The acquisition was reported by elEconomista.es and involves venture capital communication.
The Meridian Weekly
The week's largest deals and the Iberian ones, every Monday. Free.